Go Deep
The Chemours Company
The Chemours Company Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | -15,087 | -6.7 | 8.19 | 21.75 | 1,314.57 |
| Oct 2026 | -8,721 | -6.6 | 8.06 | 17.58 | 1,281.97 |
| Oct 2026 | -56,141 | -6.5 | -40.54 | 17.58 | 1,257.08 |
| Oct 2026 | -55,542 | -6.4 | -39.47 | 17.58 | 1,220.08 |
| Oct 2026 | -55,645 | -6.6 | -39.65 | 17.58 | 1,225.95 |
| Oct 2026 | -55,354 | -6.3 | -39.13 | 17.58 | 1,206.67 |
| Oct 2026 | -55,149 | -6.2 | -38.76 | 17.58 | 1,196.58 |
| Oct 2026 | -55,748 | -6.4 | -39.84 | 17.58 | 1,229.77 |
| Oct 2026 | -55,696 | -6.4 | -39.74 | 17.58 | 1,223.89 |
| Oct 2026 | -55,850 | -6.5 | -40.02 | 17.58 | 1,229.91 |
The Chemours Company Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 1,591,000,000.0 | 1,381,000,000.0 | 1,330,000,000.0 | 1,495,000,000.0 |
| Net Profit | -274,000,000.0 | -29,000,000.0 | -61,000,000.0 | 60,000,000.0 |
| EPS | -1.8 | -0.2 | — | 0.4 |
The Chemours Company Revenue & Profit: Last 4 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | 5,808,000,000.0 | 5,782,000,000.0 | 6,078,000,000.0 | 6,831,000,000.0 |
| Net Profit | -386,000,000.0 | 69,000,000.0 | -253,000,000.0 | 578,000,000.0 |
| EPS | -2.6 | 0.6 | -1.7 | 3.7 |
The Chemours Company Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 7,382,000,000.0 | 7,509,000,000.0 | 8,251,000,000.0 | 7,640,000,000.0 | — |
| Total Liabilities | 7,131,000,000.0 | 6,937,000,000.0 | 7,512,000,000.0 | 6,533,000,000.0 | — |
| Total Equity | 250,000,000.0 | 571,000,000.0 | 737,000,000.0 | 1,107,000,000.0 | — |
Owes vs Owns
The Chemours Company owed $1.01 for every $1 it owned in Jun 2026, up from $0.86 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 1.01× | 0.97× | 0.92× | 0.91× | 0.86× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
The Chemours Company Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 9.1%Receivables 9.2%Inventory 21.3%Fixed assets (tangible) 45.4%Intangible assets 0.7%Long-term investments 2.2%Other assets 12.3%
How it's funded — Dec 2025
Short-term debt 0.6%Long-term debt 55.5%Payables 12.6%Other liabilities 27.9%Shareholders' equity 3.4%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 670.0 | 713.0 | 1,203.0 | 1,102.0 |
| Receivables | 679.0 | 770.0 | 610.0 | 626.0 |
| Inventory | 1,569.0 | 1,463.0 | 1,352.0 | 1,404.0 |
| Fixed assets (tangible) | 3,349.0 | 3,453.0 | 3,476.0 | 3,411.0 |
| Intangible assets | 48.0 | 49.0 | 105.0 | 115.0 |
| Long-term investments | 160.0 | 152.0 | 158.0 | 175.0 |
| Other assets | 907.0 | 909.0 | 1,347.0 | 807.0 |
| Liabilities & equity | ||||
| Short-term debt | 42.0 | 54.0 | 51.0 | 43.0 |
| Long-term debt | 4,099.0 | 4,059.0 | 3,987.0 | 3,590.0 |
| Payables | 929.0 | 1,134.0 | 1,134.0 | 1,210.0 |
| Other liabilities | 2,061.0 | 1,690.0 | 2,340.0 | 1,690.0 |
| Shareholders' equity | 251.0 | 572.0 | 739.0 | 1,107.0 |
| Net tangible assets | 202.0 | 522.0 | 632.0 | 992.0 |
The Chemours Company Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 264,000,000.0 | -633,000,000.0 | 556,000,000.0 | 755,000,000.0 | — |
| Investing Activities | -206,000,000.0 | -353,000,000.0 | -229,000,000.0 | -284,000,000.0 | — |
| Financing Activities | -126,000,000.0 | -36,000,000.0 | 172,000,000.0 | -686,000,000.0 | — |